Successful non-operative management of right coronary artery perforation during percutaneous coronary intervention in a patient receiving abciximab and aspirin.
We report a case of successful non-operative treatment of coronary artery perforation that occurred during percutaneous transluminal coronary angioplasty. The patient was receiving abciximab, aspirin and heparin. The perforation was recognized immediately and managed by partial reversal of heparin and inflation of a non-compliant balloon at the perforation site. The perforation sealed completely. The patient was discharged asymptomatic the following day.
Del Campo
C
C
301 West Bastanchury Road, Suite 195, Fullerton, CA 92835, USA. cdelcampo@pol.net.
Zelman
R
R
D000077284:Abciximab; D000368:Aged; D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects*; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D000925:Anticoagulants / Q000008:administration & dosage; D001241:Aspirin / Q000008:administration & dosage*; D003327:Coronary Disease / Q000175:diagnosis / Q000628:therapy*; D003331:Coronary Vessels / Q000293:injuries*; D005500:Follow-Up Studies; D006801:Humans; D007140:Immunoglobulin Fab Fragments / Q000008:administration & dosage*; D008297:Male; D016896:Treatment Outcome; D014950:Wounds, Penetrating / Q000209:etiology* / Q000628:therapy*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D000911:Antibodies, Monoclonal; D000925:Anticoagulants; D007140:Immunoglobulin Fab Fragments; D001241:Aspirin; D000077284:Abciximab